"We were taking a leap of faith because there was nothing else there."
[ Ссылка ]
Parents of two sons, one of whom has CLN2 (Batten disease), talk about how they considered enrolling their young son in the trial: they learned from a previous trial in Europe. "When you get a diagnosis that your child is going to pass away, the side effects are not a top priority. It goes back to doing something. Let's do this."
For more content like this, visit courageousparentsnetwork.org
